BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 17, 2018
View Archived Issues
Neutrophil 'ghosts' drive severe asthma
Read More
To sleep, perchance to reshape your transcriptome
Read More
MicroRNA affects neuropathic pain
Read More
Targeted drug delivery using humanized Sialyl Tn-specific antibodies for ovarian cancer treatment
Read More
First patient dosed in Inovio's phase I/II study of Pennvax-GP
Read More
Release of phase IIa clinical data concerning a first-in-class drug for type 2 diabetes treatment
Read More
Metabolism targeting compound kills brain tumor cells
Read More
Development of novel broad coverage human papilloma virus vaccines
Read More
Sihuan Pharmaceutical begins phase II study of pirotinib
Read More
Principia Biopharma patents proteasome subunit beta type-8/beta type-9 inhibitors
Read More
Fasinumab topline phase III data presented in patients with chronic pain from OA of the knee or hip
Read More
TrovaGene completes second dosing cohort in phase Ib/II study of onvansertib in AML
Read More
Lenvatinib approved in the U.S. for unresectable hepatocellular carcinoma
Read More
HitGen to collaborate with LG Chem on drug discovery using DNA-encoded libraries
Read More
Dose escalation cleared to continue in first-in-human MAGE-A4 SPEAR T-cell trial
Read More
ADAM-17 inhibitor ZLDI-8 increases cancer sensitivity to chemotherapeutic drugs
Read More
RXi Pharmaceuticals, Karolinska Institutet collaborate on sd-rxRNA for cancer immunotherapy
Read More
